Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

Global pharmaceutical giant Eli Lilly & Co. is considering ... $550 million biomanufacturing plant for pharmaceutical company Amgen. Instead, Amgen picked North Carolina's Research Triangle ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina ... drugmakers such as Eli Lilly, Johnson & Johnson ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker ... investments by drugmakers such as ...

Many investments Mr. Trump claims credit for predate his return to office or are based on vague future pledges. Here's a fact ...

Merck said on Tuesday it has opened a $1-billion facility at its North ... Eli Lilly has since announced plans to invest at least $27 billion to build four new manufacturing plants in ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced ... The company also has announced new sites at Research Triangle Park in Concord, North Carolina, and the acquisition and ...

Eli Lilly said Wednesday it will invest ... which included the development of new manufacturing sites in Wisconsin and North Carolina, as well as expansions in its home state of Indiana.

The company's other U.S. plants include sites in North Carolina, Indiana and Wisconsin. The new investments aren't solely dedicated to Eli Lilly's current and future obesity and diabetes treatments.

Drugmaker Eli Lilly plans ... over the next five years. Lilly previously invested $23 billion from 2020 to 2024 for new manufacturing sites in Wisconsin and North Carolina and expansions in ...

Eli Lilly has unveiled ... with state authorities over where the new sites will be located. Recently, it began construction work on a plant at North Carolina’s Research Triangle Park as well ...